Long-Term Safety Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate In Patients With Moderate To Severe COPD: The Augment COPD Extension Trial

被引:0
|
作者
Rennard, S. I. [1 ]
D'Urzo, A. D. [2 ]
Donohue, J. F. [3 ]
He, T. [4 ]
Shrestha, P. [4 ]
Leselbaum, A. [5 ]
Caracta, C. [4 ]
机构
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Forest Res Inst, Jersey City, NJ USA
[5] Almirall SA, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A6008
引用
收藏
页数:1
相关论文
共 50 条
  • [1] The AUGMENT COPD Trial: Efficacy and Safety of a Fixed-Dose Combination of Aclidinium Bromide and Formoterol Fumarate in COPD Patients
    D'Urzo, Anthony
    Rennard, Stephen
    Mergel, Victor
    Gil, Esther Garcia
    Leselbaum, Anne
    Caracta, Cynthia
    CHEST, 2014, 145 (03)
  • [2] Long-term Safety of a Fixed-Dose Combination of Aclidinium Bromide/Formoterol Fumarate in Patients With Stable Moderate to Severe COPD
    Make, Barry
    Donohue, James
    Zhong, Xiaoyun
    Leselbaum, Anne
    Caracta, Cynthia
    CHEST, 2014, 145 (03)
  • [3] Efficacy Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate On Bronchodilation Over 1 Year: Augment COPD Extension Trial In Patients With Moderate To Severe COPD
    D'Urzo, A. D.
    Rennard, S. I.
    Kerwin, E. M.
    He, T.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [4] Efficacy and safety of fixed-dose combination aclidinium bromide/formoterol fumarate in patients with COPD: Results from the AUGMENT COPD trial
    D'Urzo, Anthony
    Mergel, Victor
    Leselbaum, Anne
    Caracta, Cynthia
    CHEST, 2013, 144 (04)
  • [5] Efficacy And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination In Patients With Moderate To Severe COPD, Stratified By COPD Severity
    D'Urzo, A.
    Singh, S. D.
    Kerwin, E. M.
    Lakkis, H.
    Chuecos, F.
    De Miquel, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [6] Twice-Daily Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination: Lung Function Improvements In The Augment COPD Trial In Patients With Moderate To Severe COPD
    D'Urzo, A. D.
    Rennard, S. I.
    Kerwin, E. M.
    Mergel, V.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [7] Fixed-Dose Combination Of Aclidinium Bromide/formoterol Fumarate Improve Breathlessness And Health Status In COPD Patients: Augment COPD Trial
    Rennard, S. I.
    D'Urzo, A. D.
    Jones, P. W.
    Mergel, V.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [8] Long-term safety of aclidinium bromide/formoterol fumarate fixed-dose combination: Results of a randomized 1-year trial in patients with COPD
    Donohue, James F.
    Soong, Weily
    Wu, Xiao
    Shrestha, Pomy
    Lei, Alejhandra
    RESPIRATORY MEDICINE, 2016, 116 : 41 - 48
  • [9] Efficacy And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination In Patients With Moderate To Severe COPD, Stratified By Inhaled Corticosteroid Use
    Bateman, E. D.
    Chapman, K. R.
    Rennard, S. I.
    Lakkis, H.
    Moya, M.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [10] Safety And Tolerability Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate: Results Of Two 6-Month Studies In Patients With Moderate To Severe COPD
    Make, B. J.
    D'Urzo, A. D.
    Jones, P. W.
    Mergel, V.
    Molins, E.
    Shrestha, P.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189